ChronoScale Holdings Corp — Form 8-K
Filed September 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
ChronoScale Intermediate LLC (formerly Ekso Bionics Holdings) amended its $2,000,000 secured promissory note with B. Riley Commercial Capital, extending the maturity date from September 12, 2025 to November 12, 2026. The amendment permits a 'Permitted Disposition' (sale of Ekso Bionics Inc., the parent/guarantor) without triggering a Change of Control clause or accelerating repayment, and provides automatic lien release upon sale consummation.
Why this rating
Debt maturity extension and covenant relief material to $15.6M company (12.8% of market cap), but reflects distress mitigation rather than growth. Amendment structure signals potential asset sale/restructuring; neutral pending outcome clarity.
Price action (we called it neutral)
before filing · preread $18.65 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.